How big is the Sodium-dependent Glucose Co-transporter 2 Market?

The Sodium-dependent Glucose Co-transporter 2 Market size is expected to reach USD 11.42 billion in 2024 and grow at a CAGR of 8.68% to reach USD 17.32 billion by 2029. Read More

What is the current Sodium-dependent Glucose Co-transporter 2 Market size?

In 2024, the Sodium-dependent Glucose Co-transporter 2 Market size is expected to reach USD 11.42 billion. Read More

Who are the key players in Sodium-dependent Glucose Co-transporter 2 Market?

Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals and Astellas are the major companies operating in the Sodium-dependent Glucose Co-transporter 2 Market. Read More

Which is the fastest growing region in Sodium-dependent Glucose Co-transporter 2 Market?

Middle East and North Africa is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Sodium-dependent Glucose Co-transporter 2 Market?

In 2024, the North America accounts for the largest market share in Sodium-dependent Glucose Co-transporter 2 Market. Read More

What years does this Sodium-dependent Glucose Co-transporter 2 Market cover, and what was the market size in 2023?

In 2023, the Sodium-dependent Glucose Co-transporter 2 Market size was estimated at USD 10.43 billion. The report covers the Sodium-dependent Glucose Co-transporter 2 Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sodium-dependent Glucose Co-transporter 2 Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Companies

This report lists the top Sodium-dependent Glucose Co-transporter 2 (SGLT 2) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) industry.